β-secretase processing of the Alzheimer’s amyloid protein precursor (APP)

被引:0
|
作者
Laura Marlow
Melissa Cain
Miguel A. Pappolla
Kumar Sambamurti
机构
[1] Medical University of South Carolina,Department of Pathology
[2] Northwest Center for Medical Education,undefined
[3] University of South Alabama,undefined
来源
关键词
BACE1; memapsin-2; amyloid; trafficking; aspartyl protease;
D O I
暂无
中图分类号
学科分类号
摘要
An integral membrane aspartyl protease, BACE, is responsible for β-secretase processing of the β-amyloid precursor protein (APP) to the large secreted sAPPβ and membrane-bound CTFβ of 99 residues. CTFβ is subsequently cleaved within the membrane by γ-secretase to the amyloid β protein (Aβ) that is deposited in the Alzheimer’s disease (AD) brain. In this manuscript, we argue that BACE is not limiting for Aβ production and report the existence of a high molecular weight complex of BACE that is more active than the monomer. We also present evidence that the BACE complex is enriched in lipid raft fractions prepared from brain membranes. These findings support the hypothesis that cleavage by BACE is limited by trafficking of APP (<10%) to a lipid raft-derived compartment containing the BACE complex. In addition, the localization of the BACE complex to lipid rafts can explain previous findings that cholesterol and glycosylphosphatidylinositol (GPI)-anchored proteins are necessary for β-secretase processing of APP. We propose that the BACE complex is a better drug target than the monomer for specific inhibition of Aβ biogenesis.
引用
收藏
页码:233 / 239
页数:6
相关论文
共 50 条
  • [41] Eta-secretase-like processing of the amyloid precursor protein (APP) by the rhomboid protease RHBDL4
    Penalva, Ylauna Christine Megane
    Paschkowsky, Sandra
    Recinto, Sherilyn Junelle
    Duchesne, Anthony
    Hammond, Thomas
    Spiegler, Pascal
    Jansen, Gregor
    Levet, Clemence
    Charron, Francois
    Freeman, Matthew
    Mckinney, R. Anne
    Trempe, Jean-Francois
    Munter, Lisa Marie
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (08)
  • [43] Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease
    Guriqbal S Basi
    Susanna Hemphill
    Elizabeth F Brigham
    Anna Liao
    Danielle L Aubele
    Jeanne Baker
    Robin Barbour
    Michael Bova
    Xiao-Hua Chen
    Michael S Dappen
    Tovah Eichenbaum
    Erich Goldbach
    Jon Hawkinson
    Rose Lawler-Herbold
    Kang Hu
    Terence Hui
    Jacek J Jagodzinski
    Pamela S Keim
    Dora Kholodenko
    Lee H Latimer
    Mike Lee
    Jennifer Marugg
    Matthew N Mattson
    Scott McCauley
    James L Miller
    Ruth Motter
    Linda Mutter
    Martin L Neitzel
    Huifang Ni
    Lan Nguyen
    Kevin Quinn
    Lany Ruslim
    Christopher M Semko
    Paul Shapiro
    Jenifer Smith
    Ferdie Soriano
    Balazs Szoke
    Kevin Tanaka
    Pearl Tang
    John A Tucker
    Xiacong Michael Ye
    Mei Yu
    Jing Wu
    Ying-zi Xu
    Albert W Garofalo
    John Michael Sauer
    Andrei W Konradi
    Daniel Ness
    George Shopp
    Michael A Pleiss
    Alzheimer's Research & Therapy, 2
  • [44] The role of presenilin-1 in the γ-secretase cleavage of the amyloid precursor protein of Alzheimer's disease
    Octave, JN
    Essalmani, R
    Tasiaux, B
    Menager, J
    Czech, C
    Mercken, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) : 1525 - 1528
  • [45] Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease
    Zhang, Zhentao
    Song, Mingke
    Liu, Xia
    Kang, Seong Su
    Duong, Duc M.
    Seyfried, Nicholas T.
    Cao, Xuebing
    Cheng, Liming
    Sun, Yi E.
    Yu, Shan Ping
    Jia, Jianping
    Levey, Allan I.
    Ye, Keqiang
    NATURE COMMUNICATIONS, 2015, 6
  • [46] Levels of α- and β-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients
    Sennvik, K
    Fastbom, J
    Blomberg, M
    Wahlund, LO
    Winblad, B
    Benedikz, E
    NEUROSCIENCE LETTERS, 2000, 278 (03) : 169 - 172
  • [47] Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease
    Zhentao Zhang
    Mingke Song
    Xia Liu
    Seong Su Kang
    Duc M. Duong
    Nicholas T. Seyfried
    Xuebing Cao
    Liming Cheng
    Yi E. Sun
    Shan Ping Yu
    Jianping Jia
    Allan I. Levey
    Keqiang Ye
    Nature Communications, 6
  • [48] Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease
    Basi, Guriqbal S.
    Hemphill, Susanna
    Brigham, Elizabeth F.
    Liao, Anna
    Aubele, Danielle L.
    Baker, Jeanne
    Barbour, Robin
    Bova, Michael
    Chen, Xiao-Hua
    Dappen, Michael S.
    Eichenbaum, Tovah
    Goldbach, Erich
    Hawkinson, Jon
    Lawler-Herbold, Rose
    Hu, Kang
    Hui, Terence
    Jagodzinski, Jacek J.
    Keim, Pamela S.
    Kholodenko, Dora
    Latimer, Lee H.
    Lee, Mike
    Marugg, Jennifer
    Mattson, Matthew N.
    McCauley, Scott
    Miller, James L.
    Motter, Ruth
    Mutter, Linda
    Neitzel, Martin L.
    Ni, Huifang
    Lan Nguyen
    Quinn, Kevin
    Ruslim, Lany
    Semko, Christopher M.
    Shapiro, Paul
    Smith, Jenifer
    Soriano, Ferdie
    Szoke, Balazs
    Tanaka, Kevin
    Tang, Pearl
    Tucker, John A.
    Ye, Xiacong Michael
    Yu, Mei
    Wu, Jing
    Xu, Ying-zi
    Garofalo, Albert W.
    Sauer, John Michael
    Konradi, Andrei W.
    Ness, Daniel
    Shopp, George
    Pleiss, Michael A.
    ALZHEIMERS RESEARCH & THERAPY, 2010, 2 (06):
  • [49] Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus
    Al-kuraishy, Hayder M.
    Sulaiman, Ghassan M.
    Mohammed, Hamdoon A.
    Dawood, Retaj A.
    Albuhadily, Ali K.
    Al-Gareeb, Ali I.
    Abomughaid, Mosleh M.
    Klionsky, Daniel J.
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2025, 45 (01)
  • [50] Suppression of Alzheimer amyloid precursor protein (APP) expression by exogenous APP mRNA
    Ramakrishna, N
    Smedman, M
    Gillam, B
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 326 (02) : 243 - 251